Consensus statement urges caution in using ketamine for treating depression

With ketamine infusion therapy generating significant interest for the treatment of mood disorders despite a lack of evidence from large‐scale trials, a subgroup of an American Psychiatric Association (APA) task force has issued a consensus statement on critical issues to consider in this off‐label use of ketamine. Among the statement's recommendations are that the number of ketamine treatments should be limited to the minimum necessary to achieve response and that providers should assess for the patient's potential to develop a ketamine use disorder.

Source: The Brown University Psychopharmacology Update - May 19, 2017 Category: Psychiatry Tags: Depression Treatment Source Type: research